JP Morgan Chase’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
Other funds holding MPT
VPM
VCM
WAM
JP Morgan Chase's MPT Position: Q1 2026 in Review
JP Morgan Chase reduced its Medical Properties Trust (MPT) stake by 16% in Q1 2026, selling an estimated $1.53M and leaving 1,511,657 shares worth $6.89M. The position accounts for ﹤0.01% of the portfolio, ranked #3018.
JP Morgan Chase first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $83.8M in Q4 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.
- JP Morgan Chase held 1,511,657 shares of Medical Properties Trust worth $6.89M as of Q1 2026.
- JP Morgan Chase sold 294,244 Medical Properties Trust shares in Q1 2026, an estimated $1.53M.
- Medical Properties Trust made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3018 holding.
- JP Morgan Chase first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Medical Properties Trust position peaked at $83.8M in Q4 2022.
- 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.